Larkspur Biosciences
Watertown
About Larkspur Biosciences
Larkspur's strategy focuses on the particular ways in which tumours hijack the immune system by developing precision immunotherapies for molecularly defined patient groups to overcome the bottlenecks that allow the tumour to subvert the immune system.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $35.5M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2023)
- Website: larkspur.bio
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/larkspur-biosciences-77459 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.